BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20220101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230612
DTEND;VALUE=DATE:20230614
DTSTAMP:20260516T064227
CREATED:20230323T114637Z
LAST-MODIFIED:20230323T114637Z
UID:36890-1686528000-1686700799@www.pharmajournalist.com
SUMMARY:6th Annual Pre-Filled Syringes West Coast Conference
DESCRIPTION:Assessing Device Development and Regulation for Advanced Innovation\nSponsors: Datwyler\, Haselmeier\, Mitsubishi Gas Chemical\, Nemera\, ZEON \nExhibitors: Credence MedSystems\, Kymanox\, Noble\, Owen Mumford Pharmaceutical Services\, SCHERDEL Medtec \nSAE Media Group’s 7th Annual Pre-Filled Syringes West Coast Conference will be back for 2023 in San Diego to bring together the device developers\, innovative biotech\, and big pharma. \nThis year’s conference will explore the exciting advances in the combination product drug delivery space and a future outlook exploring how pharma\, device developers and regulators can work together to encourage innovation. \nWith the injectable drug delivery industry rapidly advancing year-to-year\, administration using pre-filled syringes\, auto-injectors\, and pen-injectors are increasingly common. Innovations in device technology\, such as connected devices are leading the way in device design in addition to injectable delivery devices for novel and large volume drugs. With the need for self-administration growing\, there is an enhanced demand for on-body injectors and digitalised health as well as patient centricity. We are beginning to see environmental sustainability being incorporated into aspects of device lifecycle from design to manufacturing and the use of the device. This year’s conference looks to address these hot topics through case studies and industry insights. \nAs part of SAE’s leading injectable drug delivery conferences this is a must attend event; not only will the conference bring delegates key insights to enhance their drug device portfolio\, but it will also give them the opportunity to network with key industry players.  \nBenefits of Attending: \n\nEngage with industry representatives about the latest technologies and advances within the injectable device market and directions to take to advance your device portfolio\nGain insight into new technologies for wearable injectors he delivery of novel and large volume drugs\nUnderstand the latest regulatory requirements and guidance to ensure your combination products are compliant such as meeting essential performance requirements\nDelve into aspects of primary packaging such as material components to consider during device design to ensure drug stability and safety\nExplore how digital technologies such as companion apps are being incorporated into drug delivery devices to improve user-centricity\n\nWho should attend: \nDirectors\, Heads of Departments and Managers for the following areas: \n\nDevice Development\nDevice Engineering\nCombination Product Development\nDrug Delivery Devices\nPrimary Packaging Development\nDigital Health\nLarge Volume Drug Delivery\nNovel Drug Product Formulation\nRegulatory Affairs\n\nEarly Bird Rates: \n\nEB1 – 28 Feb 2023 – US$400\nEB2 -31 March 2023 – US$200\nEB3 – 28 April 2023 – US$100\n\nAdditional Contact Info: \nT: +44 (0)20 7827 \nE: Hannah.Blake@saemediagroup.com \nW: http://www.prefilled-syringes-westcoast.com/PharmaJournalist-El
URL:https://www.pharmajournalist.com/event/6th-annual-pre-filled-syringes-west-coast-conference/
LOCATION:San Diego\, CA\, USA
ORGANIZER;CN="SAE Media Group":MAILTO:events@saemediagroup.com
END:VEVENT
END:VCALENDAR